697306-45-9

Basic information

• Product Name: (1-Phenyl-4-piperidyl)Methanol
• Synonyms: (1-Phenyl-4-piperidyl)Methanol;1-Phenyl-4-piperidinemethanol;(1-Phenylpiperidin-4-yl)
• CAS NO: 697306-45-9
• Molecular Formula: C₁₂H₁₇NO
• Molecular Weight: 191
• Mol File: 697306-45-9.mol

Chemical Properties

• Boiling Point: 327.221 °C at 760 mmHg
• Flash Point: 162.998 °C
• Appearance: /
• Density: 1.061
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.94±0.10(Predicted)
• CAS DataBase Reference: (1-Phenyl-4-piperidyl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1-Phenyl-4-piperidyl)Methanol(697306-45-9)
• EPA Substance Registry System: (1-Phenyl-4-piperidyl)Methanol(697306-45-9)

Safety Data

• Hazardous Substances Data: 697306-45-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(1-Phenyl-4-piperidyl)Methanol is used as an intermediate compound for the synthesis of various pharmaceuticals. Its presence in the structure of these drugs can contribute to their therapeutic effects and properties.
Used in Organic Synthesis:
(1-Phenyl-4-piperidyl)Methanol is used as a building block in the synthesis of more complex organic molecules. Its versatile structure allows it to be incorporated into a wide range of chemical reactions, leading to the creation of new compounds with potential applications in various fields.

Upstream product

• 247022-37-3 ethyl 1-phenylpiperidine-4-carboxylate 

Downstream Products

• 111153-74-3 4-formyl-1-phenylpiperidine 
• 1196047-35-4 methyl 1-[(1-phenylpiperidin-4-yl)methyl]-1H-indole-7-carboxylate 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PLATELET AGGREGATION

The present invention provides compounds of Formula I: wherein Y, AA, W, R3, R2, R4, R5, R6, R7, X1, X2, X3, X4 and X5 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.

AMINE COMPOUNDS

The present invention provide a compound of the formula:wherein ring A represents an aromatic ring optionally having substituents; B, Y and Ya are the same or different and each represents a bond, etc.; R1 and R2 are the same or different and each represents a hydrogen atom, etc.; R3 represents a hydrogen atom, etc.; R4 and R5 are the same or different and each represents a hydrogen, etc.; R6 represents an indolyl group optionally having substituents; and Z and Za are the same or different and each represents a hydrogen atom, etc.; or a salt thereof or a prodrug thereof, having a somatostatin receptor binding inhibition activity and is useful for preventing and/or treating diseases associated with somatostatin.